Results 121 to 130 of about 38,752 (185)

VHHs as therapeutic tools in tauopathy models

open access: yes
Les tauopathies sont un groupe de maladies neurodégénératives hétérogènes ayant pour caractéristique commune une accumulation intracellulaire d'agrégats composés de protéine tau. Dans la maladie d'Alzheimer, la pathologie tau évolue selon une progression stéréotypée, connue sous le nom de stade de Braak. Aujourd’hui ces stades sont considérés comme les
openaire   +1 more source

Poxvirus dsDNA genomes differentially activate AIM2 or NLRP3 inflammasomes in human primary cells. [PDF]

open access: yesEMBO J
Tesfamariam YM   +20 more
europepmc   +1 more source

More tools to uncover cancer cells. [PDF]

open access: yesMol Ther Oncol
Pignataro MF, Santos J.
europepmc   +1 more source

Glycan-based biological degraders targeting the cytokine immune axis. [PDF]

open access: yesCommun Biol
Seifert M   +10 more
europepmc   +1 more source

Development of a VHH that inhibits the binding of neuronal pentraxin 2 to a postsynaptic glutamate receptor, AMPAR. [PDF]

open access: yesJ Biol Chem
Yokoo T   +6 more
europepmc   +1 more source

Neutralization of Crimean-Congo hemorrhagic fever pseudotyped virions with heavy chain antibodies. [PDF]

open access: yesVirol Sin
Qian K   +18 more
europepmc   +1 more source

In vivo CAR T cell generation using retargeted and functionalized lentiviral vectors with reduced immunogenicity. [PDF]

open access: yesNat Commun
Ibrahim KE   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy